Edwards Lifesciences Corp Quarterly Common Stock, Shares, Outstanding from Q2 2010 to Q4 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Edwards Lifesciences Corp quarterly Common Stock, Shares, Outstanding history and growth rate from Q2 2010 to Q4 2024.
  • Edwards Lifesciences Corp Common Stock, Shares, Outstanding for the quarter ending December 31, 2024 was 589M shares, a 2.08% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 589M -12.5M -2.08% Dec 31, 2024 10-K 2025-02-28
Q3 2024 590M -16.7M -2.75% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 602M -5.6M -0.92% Jun 30, 2024 10-Q 2024-07-31
Q1 2024 602M -3.6M -0.59% Mar 31, 2024 10-Q 2024-04-29
Q4 2023 601M -7.2M -1.18% Dec 31, 2023 10-K 2025-02-28
Q3 2023 607M -12.9M -2.08% Sep 30, 2023 10-Q 2023-10-27
Q2 2023 608M -11.9M -1.92% Jun 30, 2023 10-Q 2023-07-28
Q1 2023 606M -15.4M -2.48% Mar 31, 2023 10-Q 2023-04-28
Q4 2022 608M -15.8M -2.53% Dec 31, 2022 10-K 2024-02-12
Q3 2022 619M -4.8M -0.77% Sep 30, 2022 10-Q 2022-10-28
Q2 2022 620M -3.3M -0.53% Jun 30, 2022 10-Q 2022-07-29
Q1 2022 621M -400K -0.06% Mar 31, 2022 10-Q 2022-04-28
Q4 2021 624M -200K -0.03% Dec 31, 2021 10-K 2023-02-13
Q3 2021 624M +1.3M +0.21% Sep 30, 2021 10-Q 2021-10-29
Q2 2021 623M +1.7M +0.27% Jun 30, 2021 10-Q 2021-07-30
Q1 2021 622M +415M +201% Mar 31, 2021 10-Q 2021-04-28
Q4 2020 624M +415M +199% Dec 31, 2020 10-K 2022-02-14
Q3 2020 623M +414M +199% Sep 30, 2020 10-Q 2020-10-26
Q2 2020 621M +414M +199% Jun 30, 2020 10-Q 2020-07-27
Q1 2020 207M -1.9M -0.91% Mar 31, 2020 10-Q 2020-04-28
Q4 2019 209M +1.4M +0.67% Dec 31, 2019 10-K 2021-02-12
Q3 2019 209M -600K -0.29% Sep 30, 2019 10-Q 2019-10-25
Q2 2019 208M -1.3M -0.62% Jun 30, 2019 10-Q 2019-07-26
Q1 2019 208M -2.3M -1.09% Mar 31, 2019 10-Q 2019-04-26
Q4 2018 208M -2M -0.95% Dec 31, 2018 10-K 2020-02-14
Q3 2018 209M -2.5M -1.18% Sep 30, 2018 10-Q 2018-10-26
Q2 2018 209M -1.9M -0.9% Jun 30, 2018 10-Q 2018-07-27
Q1 2018 211M +300K +0.14% Mar 31, 2018 10-Q 2018-04-27
Q4 2017 210M -1.9M -0.9% Dec 31, 2017 10-K 2019-02-15
Q3 2017 212M -2.1M -0.98% Sep 30, 2017 10-Q 2017-10-27
Q2 2017 211M -1.6M -0.75% Jun 30, 2017 10-Q 2017-07-28
Q1 2017 210M -1.5M -0.71% Mar 31, 2017 10-Q 2017-04-28
Q4 2016 212M -3.8M -1.76% Dec 31, 2016 10-K 2018-02-16
Q3 2016 214M +106M +98.4% Sep 30, 2016 10-Q 2016-10-28
Q2 2016 213M +105M +98% Jun 30, 2016 10-Q 2016-07-29
Q1 2016 212M +104M +97.1% Mar 31, 2016 10-Q 2016-04-29
Q4 2015 215M +108M +99.8% Dec 31, 2015 10-K 2017-02-17
Q3 2015 108M +800K +0.75% Sep 30, 2015 10-Q 2015-10-29
Q2 2015 107M +1.4M +1.32% Jun 30, 2015 10-Q 2015-07-29
Q1 2015 108M +2.2M +2.09% Mar 31, 2015 10-Q 2015-04-29
Q4 2014 108M -1.5M -1.37% Dec 31, 2014 10-K 2016-02-19
Q3 2014 107M -2.5M -2.29% Sep 30, 2014 10-Q 2014-10-31
Q2 2014 106M -6.2M -5.53% Jun 30, 2014 10-Q 2014-08-04
Q1 2014 105M -8.2M -7.23% Mar 31, 2014 10-Q 2014-05-02
Q4 2013 109M -5M -4.37% Dec 31, 2013 10-K 2015-02-20
Q3 2013 109M -6.6M -5.69% Sep 30, 2013 10-Q 2013-11-07
Q2 2013 112M -3.1M -2.69% Jun 30, 2013 10-Q 2013-08-06
Q1 2013 114M -500K -0.44% Mar 31, 2013 10-Q 2013-05-06
Q4 2012 114M +200K +0.18% Dec 31, 2012 10-K 2014-02-28
Q3 2012 116M +1.8M +1.58% Sep 30, 2012 10-Q 2012-11-07
Q2 2012 115M +400K +0.35% Jun 30, 2012 10-Q 2012-08-07
Q1 2012 114M -800K -0.7% Mar 31, 2012 10-Q 2012-05-09
Q4 2011 114M -900K -0.78% Dec 31, 2011 10-K 2013-02-28
Q3 2011 114M +100K +0.09% Sep 30, 2011 10-Q 2011-11-08
Q2 2011 115M +1.8M +1.59% Jun 30, 2011 10-Q 2011-08-08
Q1 2011 115M Mar 31, 2011 10-Q 2011-05-09
Q4 2010 115M Dec 31, 2010 10-K 2012-02-27
Q3 2010 114M Sep 30, 2010 10-Q 2010-11-08
Q2 2010 113M Jun 30, 2010 10-Q 2010-08-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.